Alzheimer disease trials in France

In France 85 Also abroad 820

85 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Investigation of AlzHeimer's Predictors in Subjective Memory Complainers - Extension Study
Where
Paris
Age
70 years to 95 years
People
240
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT05806697
No phaseTaking people
Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders
Where
Nantes
Age
18 years and over
People
120
Run by
Nantes University Hospital
See details and how to joinNCT06059313
Phase 4Taking people
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
Where
Montpellier
Age
60 years to 85 years
People
62
Run by
University Hospital, Montpellier
See details and how to joinNCT05924425
No phaseTaking people
Deep Learning on Amyloid Positons Emission Tomography
Where
Vandœuvre-lès-Nancy
Age
18 years to 99 years
People
40
Run by
Central Hospital, Nancy, France
See details and how to joinNCT07309107
Phase 1/2Taking people
Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease
Where
Toulouse
Age
50 years to 85 years
People
9
Run by
University Hospital, Toulouse
See details and how to joinNCT07367815 · EU 2022-502846-28-00
Phase 4Taking people
Daridorexant to treat insomnia in patients with mild cognitive impairment and mild to moderate Alzheimer disease.
Where
Montpellier Cedex 5
Age
18 years and over
People
62
Run by
Centre Hospitalier Universitaire De Montpellier
See details and how to join2023-503301-10-00
No phaseTaking people
Mitochondrial Function and Metabolomic Profile in Alzheimer's Disease and Related Dementias
Where
Nice
Age
18 years and over
People
250
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT06880406
No phaseTaking people
MIMA Pilot Study: MIcrostructure of the Medial Temporal Lobe in Early Alzheimer's Disease
Where
Rennes
Age
50 years to 80 years
People
50
Run by
Rennes University Hospital
See details and how to joinNCT06099587
No phaseNot yet taking people in France
Subjective Assessment of Spatial Orientation Abilities in Alzheimer's Disease
Where
Nancy
Age
18 years to 85 years
People
330
Run by
Central Hospital, Nancy, France
See details and how to joinNCT07616063
No phaseTaking people
Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease
Where
Amiens
Age
40 years to 85 years
People
155
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT02811653
No phaseTaking people
The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)
Where
Grenoble
Age
50 years to 95 years
People
220
Run by
University Hospital, Grenoble
See details and how to joinNCT07367880
No phaseTaking people
Evaluation of the Link Between Carotid Arterial Wall Viscosity and Major Neurocognitive Disorders
Where
Rouen
Age
70 years and over
People
140
Run by
University Hospital, Rouen
See details and how to joinNCT07205003
Phase 1Taking people
Evaluation of the safety of a strategy combining etanercept administration with repeated contrast ultrasound in patients with Alzheimer's disease: a phase I study
Where
Paris
Age
18 years and over
People
5
Run by
Hopital Fondation Adolphe De Rothschild
See details and how to join2023-505714-19-00
No phaseTaking people
Trial-Ready Cohort-Down Syndrome (TRC-DS)
Where
Paris
Age
25 years to 55 years
People
550 worldwide
Run by
University of Southern California
See details and how to joinNCT04165109
No phaseTaking people
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Where
Lille
Age
40 years to 85 years
People
102
Run by
University Hospital, Lille
See details and how to joinNCT05288842
No phaseTaking people
Diagnostic and Prognostic Value of New Quick Tests of Action Slowing in Stroke and in Cognitive Neurodegenerative Disease
Where
Amiens
Age
40 years to 85 years
People
129
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT05785156
Phase 1Taking people
Safety of a Strategy Combining Etanercept Administration With Repeated Contrast Ultrasound in Patients With Alzheimer's Disease
Where
Paris
Age
50 years to 85 years
People
5
Run by
Fondation Ophtalmologique Adolphe de Rothschild
See details and how to joinNCT06585384
No phaseNot yet taking people in France
Validation Study of the ExéSem Battery Designed to Differentiate the Contribution of Executive Functions in Semantic Disorders
Where
Lyon
Age
50 years to 90 years
People
140
Run by
Hospices Civils de Lyon
See details and how to joinNCT07573046
No phaseTaking people
Validation of an Alzheimer's Disease Marker by Fecal Assay of Amyloid Peptides and Tau Proteins
Where
Grenoble
Age
40 years and over
People
115
Run by
University Hospital, Grenoble
See details and how to joinNCT06481878
No phaseTaking people
Social & Affective Cognition in Alzheimer's Disease & Associated Disorders
Where
Lille
Age
40 years to 85 years
People
120
Run by
University Hospital, Lille
See details and how to joinNCT06338397
No phaseTaking people
Development, Standardisation and Standardisation Project for a New Memory Assessment
Where
Tours
Age
50 years and over
People
150
Run by
University Hospital, Tours
See details and how to joinNCT06564779
Phase 3Taking people
Effect of CAFfeine on Cognition in Alzheimer's Disease
Where
Amiens, Arras, Beauvais, Béthune, Caen, Calais, Dunkirk, Lens, Le Quesnoy, Lille, Roubaix, Rouen, Saint-Quentin, Seclin, Tourcoing, Valenciennes
Age
50 years and over
People
248
Run by
University Hospital, Lille
See details and how to joinNCT04570085
No phaseTaking people
Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases
Where
Paris
Age
50 years to 80 years
People
34
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07531732
No phaseTaking people
Links Between Cognitive Deficits During Normal or Pathological Aging and Slow Waves Measured in EEG
Where
Paris
Age
18 years to 85 years
People
90
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06501495
No phaseTaking people
Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-AD
Where
Paris
Age
50 years to 90 years
People
244
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06582199